Re:FDA Warning Letter to 23andMe
by dragonwriter on Monday November 25, 2013 @01:26PM
(#6795825)
Navigenics, with Navigenics Health Compass, was a competitor to 23andMe with their PGS offering, but Navigenics appears to have discontinued the competing offering (Navigenics was received initial contact from the FDA at about their product at the same time 23andMe did, they also went through similar rounds with the State of California for licensing to operate their before that.)
There's a number of other offerings that have been made in the same general space, as well.
There's a number of other offerings that have been made in the same general space, as well.